Veterinary Medicines

OTIBIOVIN ausu pilieni, šķīdums suņiem un kaķiem

Authorised
  • Salicylic acid
  • CARBETHOPENDECINII BROMIDUM
  • Gentamicin sulfate
  • Triamcinolone acetonide
Download as PDF

Product identification

Medicine name:
OTIBIOVIN ausu pilieni, šķīdums suņiem un kaķiem
Active substance:
  • Salicylic acid
  • CARBETHOPENDECINII BROMIDUM
  • Gentamicin sulfate
  • Triamcinolone acetonide
Target species:
  • Dog
  • Cat
Route of administration:
  • Auricular use

Product details

Active substance and strength:
  • Salicylic acid
    5.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • CARBETHOPENDECINII BROMIDUM
    0.13
    milligram(s)
    /
    1.00
    millilitre(s)
  • Gentamicin sulfate
    2.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Triamcinolone acetonide
    0.50
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Ear drops, solution
Withdrawal period by route of administration:
  • Auricular use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QS03C
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta, a.s.
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/NRP/97/0579
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 10/12/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 10/12/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 10/12/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."